OpportunityTitle: Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01)
AdditionalInformationOnEligibility: Hispanic-serving Institutions   Historically Black Colleges and Universities (HBCUs)   Tribally Controlled Colleges and Universities (TCCUs)   Alaska Native and Native Hawaiian Serving Institutions
Description: The goal of FDA&apos;s OPD grant program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the product being developed will be superior to the existing therapy. FDA provides grants for clinical studies on safety and/or effectiveness that will either result in, or substantially contribute to, market approval of these products. Applicants must include in the application&apos;s Background and Significance section documentation to support the assertion that the orphan disease or condition to be studied is a &#147;rare disease or condition&#148; and an explanation of how the proposed study will either help support product approval or provide essential data needed for product development.
GrantorContactEmailDescription: vieda.hubbard@fda.hhs.gov
GrantorContactText: Vieda HUBBARD &lt;br/&gt;Grants Management Specialist
CloseDateExplanation: Regular Submission Dates:  February 6, 2013 and February 5, 2014    Resubmission Dates:  October 15, 2013 and October 15, 2014